Niki BioSolutions names Thomas Freeburg CFO with $250K salary, 50,000 options at $8.83

Aptorum Group Ltd

Board appointed Thomas Freeburg, 59, as CFO on Oct 9, 2026; two-year term commencing Sept 1, 2026, reporting to CEO Ian Huen.
Base salary $250,000, with $25,000 deferred until the company raises $3M cumulatively; rises to $275,000 at $5M raised; bonus up to 50% of salary.
Receives 50,000 stock options at an $8.83 exercise price under the Niki BioSolutions 2026 Equity Incentive Plan; 20 days PTO and $150/month tech allowance.
Qualifying termination severance: lump sum of remaining base salary through end of Initial Term or six months, whichever is greater, plus COBRA and full unvested equity acceleration.
Freeburg was CFO/Secretary/Treasurer of Interpace Biosciences (IDXG) from Feb 2021 to Mar 2023, with earlier SEC reporting roles at Tapestry (TPR) and Scholastic (SCHL).

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Thomas Freeburg

Chief Financial Officer

APM · Aptorum Group Ltd

Effective: 2026-09-01
Filed: October 13, 2026, 4:00 PM ET

On October 9, 2026, the Board of Directors (the “Board”) of Niki BioSolutions, Inc., a Delaware corporation (the “Company”), appointed Thomas Freeburg as the Chief Financial Officer, to serve at the discretion of the Board, for a period of two years, commencing as of September 1, 2026, unless terminated sooner by either party.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas Freeburg was appointed as Chief Financial Officer at Aptorum Group Ltd.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On October 9, 2026, the Board of Directors (the “Board”) of Niki BioSolutions, Inc., a Delaware corporation (the “Company”), appointed Thomas Freeburg as the Chief Financial Officer, to serve at the discretion of the Board, for a period of two years, commencing as of September 1, 2026, unless terminated sooner by either party.

View on SEC.gov

Aptorum Group Ltd filing history →

Source: SEC EDGAR

accession 0001213900-26-109016

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.